Brooks O'Neil
Stock Analyst at Lake Street
(0.76)
# 4,013
Out of 5,090 analysts
33
Total ratings
27.27%
Success rate
-20.09%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.50 | +128.57% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $20.92 | -42.64% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $3.50 | +128.57% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $5.24 | +281.68% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $84.53 | +30.13% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $29.38 | +2.11% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $18.67 | +280.29% | 1 | Jan 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $6.60 | +293.94% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $45.75 | +20.22% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $21.45 | -16.08% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.74 | +5.49% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $6.93 | +73.16% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $27.81 | -6.51% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.46 | +2,310.17% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $32.70 | +289.97% | 1 | Sep 15, 2020 |
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.50
Upside: +128.57%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $20.92
Upside: -42.64%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.50
Upside: +128.57%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $5.24
Upside: +281.68%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $84.53
Upside: +30.13%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $29.38
Upside: +2.11%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $18.67
Upside: +280.29%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $6.60
Upside: +293.94%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $45.75
Upside: +20.22%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $21.45
Upside: -16.08%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $4.74
Upside: +5.49%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $6.93
Upside: +73.16%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $27.81
Upside: -6.51%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.46
Upside: +2,310.17%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $32.70
Upside: +289.97%